Archived News Releases

• Dec 05, 2000 - Approval For Clinical Ia Received
• Dec 04, 2000 - Non-Brokered Private Placement
• Nov 30, 2000 - Research Facility Passes Inspection
• Nov 24, 2000 - Important Step Towards Phase I(a) Clinical Testing on Tetrodin
• Nov 02, 2000 - Further Patent Application on Tetrodin
• Oct 25, 2000 - New Patent Applications Filed on Tetrodin
• Oct 23, 2000 - Significant Progress on Validations And Ind Filing
• Oct 10, 2000 - Filed IND
• Sep 27, 2000 - A Further Validation Completed on Tetrodin
• Sep 20, 2000 - ViaVid Interviews Vice President, Shareholder Communications
• Sep 08, 2000 - Pre-IND Meeting Positive
• Sep 08, 2000 - Non-Brokered Private Placement
• Sep 07, 2000 - Confirmed Validation for Drug Product (Tetrodin) and its Drug Substance
• Aug 28, 2000 - Review of Preclinical Data on Tetrodin/Toxicology
• Aug 23, 2000 - C.O.O. Appointment
• Aug 17, 2000 - Pre-IND Meeting Date Set With HPB
• Aug 16, 2000 - Toxicology Validation Study Underway in Canada
• July 05, 2000 - Validations Now Under Way
• June 22, 2000 - Correction
• June 13, 2000 - Hardware Update
• June 07, 2000 - Update
• June 06, 2000 - New Appointment to Advisory Board
• June 02, 2000 - Non-Brokered Private Placement
• May 19, 2000 - Advisory Board Meets
• May 18, 2000 - Non-Brokered Private Placement
• May 16, 2000 - Wex Appoints Advisory Board
• May 01, 2000 - Advanced Analytical Equipment Acquired
• Apr 27, 2000 - Tetrodin Production Process Honed
• Apr 14, 2000 - Director, Regulatory Affairs, P.R.C.
• Apr 14, 2000 - Wex in Joint Collaboration With B.M.U.'S Neuropsychopharmacology Department
• Mar 22, 2000 - Eurasia Trading Places Trial Order
• Mar 17, 2000 - China Pharma News Correction
• Mar 09, 2000 - Translation Contracts Signed
• Mar 03, 2000 - Private Placement
• Mar 02, 2000 - Employee's Stock Option
• Jan 31, 2000 - Termination Of Agreement
• Jan 24, 2000 - China Pharma News Service Initates Coverage on Tetrodin(Ht)
• Jan 17, 2000 - New Patent Issued
• Dec 17, 1999 - Clinical License's Meeting Date is Set
• Oct 26, 1999 - Development Recognition of HD-4 Multi-Domain Cardiac Heart Monitor
• Oct 18, 1999 - M.D./ Pharmacologist joins International Wex Technologies Inc.
• Oct 06, 1999 - 1999 - Calgary Investment Conference
• Aug 31, 1999 - Letter of Intent Signed with Manhattan Scientific Corp.
• Jul 19, 1999 - Tetrodin(HT) Reaches Its Most Important Milestone
• July 08, 1999 - Update on Year 2000 Issue
• July 06, 1999 - All Pre-clinical Testings Of Tetrodin(HT) Now Complete
• Jun 16, 1999 - TENTATIVE AGREEMENT FOR MARKETING TETRODIN(HT) IN NORTH AMERICA
• May 17, 1999 - Distribution Contract For Non-Pharmaceutical Products
• Apr 15, 1999 - Mexico Distribution Agreement Signed
• Mar 19, 1999 - Pharmaceutical/Lobbyist Retained
• Jan 29, 1999 - Professionals To Visit China To Observe Tetrodin(Ht)'S Use On Human Addicts
• Jan 25, 1999 - Update on the United States of America Patent Issued for Tetrodin(HT)
• Dec 18, 1998 - International Wex Technologies Inc. and Angel Investments Ltd. Sign Letter of Intent...
• Dec 07, 1998 - International Wex Technologies Inc. is proceeding with a Human Clinical Test of Tetrodin(HT)
• Dec 02, 1998 - International Wex Technologies Inc. and Royal Bright Holdings Ltd. Sign Letter of Intent...
• Jul 29, 1998 - United States of America Patent Issued for Tetrodin(HT)
• Jun 30, 1998 - First Distribution Contract For The Sale Of Tetrodin(HT) Signed
• Jun 23, 1998 - News Update On The Progress Of The New Drug License Certification Testing Of Tetrodin(HT)
• May 13, 1998 - Tests Results On The Main Analgesic Actions of Tetrodin(HT) In Mice And Rats Complete
• Mar 27, 1998 - The Formation of the Beijing Aiqite Distribution Ltd is confirmed.
• Aug 15, 1997 - Letter of Intent Signed

2001 news>